Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab′)2 anti-C3 micro enzyme immunoassays

doi:10.1016/0022-1759(85)90258-3

Journal of Immunological Methods

Volume 83, Issue 2, 7 November 1985, Pages 363-370

https://doi.org/10.1016/0022-1759(85)90258-3 Get rights and content

Abstract

Two micro enzyme immunoassays (microEIA) for circulating immune complexes (CICs) are described. The Raji cell microEIA was similar in sensitivity, reproducibility and specificity to the Raji radioimmunoassay. The F(ab′)₂ anti-C₃ microEIA was comparable to the 2 Raji cell assays. The 2 microEIAs for CICs were used to analyze sera from patients with systemic lupus erythematosus (SLE), the acquired immune deficiency syndrome (AIDS) and from hemophiliacs with AIDS-like symptoms. The microEIAs were very sensitive in detecting CICs in pathologic sera. In contrast, only 3% of normals (n=30) were positive in the Raji microEIA while none were positive in the F(ab′)₂ anti-C₃ microEIA. The initial high positivity of some normals (9/30) in the F(ab′)₂ microEIA was due to bovine serum albumin (BSA)-anti-BSA immune complex formation in vitro and was corrected when human albumin was used in buffer preparation instead of BSA. The reagents required for the microEIAs are more stable and less expensive than those required for the RIAs and the need for facilities to deal with ¹²⁵-labeling and disposal is avoided.

References (11)

C.G. Cochrane et al.
Adv. Immunol.
(1973)
S.C. Jordan et al.
Clin. Immunol. Immunopathol.
(1983)
A.N. Theofilopoulos et al.
Adv. Immunol.
(1980)
C. Cunningham-Rundles et al.
Clin. Exp. Immunol.
(1980)
M. Delire et al.
Nature (London)
(1978)

There are more references available in the full text version of this article.

Cited by (16)

Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations
1997, Biologicals
Anticomplementary activity (ACA) of aggregate in intravenous immunoglobulin preparations (IVIG) was investigated using the modified Kabat and Meyer classical complement consumption method recommended by the European Pharmacopoeia and a C1q-coated microtitre enzyme-linked immunosorbent assay (ELISA). The physical characteristics of aggregates were found to affect complement binding. Aggregates formed by heating IVIG preparations at acid pH bound complement poorly, while aggregates formed by heating IVIG at neutral pH showed high ACA. This suggests that analysis of complement binding capacity provides a level of aggregate characterization of aggregates which is additional to quantitation by high-performance liquid chromatography (HPLC). The correlation (r=0·98) between the two tests was good when aggregates formed at neutral pH were compared, but decreased (r=0·57) when aggregates formed at acid pH were included. A comparison of the results showed that there were no significant differences in the classification of aggregates with acceptable/unacceptable (i.e. pass/fail outcome) values of ACA. Between assay variation (CV=7·6%) was lower in the ELISA tests compared with the complement consumption assay (where percentage binding varied from 78·9% to 100%). Both assays are justified for the evaluation of ACA in therapeutic IVIG. The ELISA had the advantage in being more precise, less dependent on reagent source and requiring less technical expertise.
Detection of circulating immune complexes with polyethylene glycol precipitation F(ab′)<inf>2</inf> anti-C<inf>3</inf> ELISA
1990, Journal of Immunological Methods
A polyethylene glycol (PEG) precipitation F(ab′)₂ anti-C₃ ELISA for the detection of complement-fixing IgG circulating immune complexes (CIC) is described. For this assay, test sera were treated with 3.5% PEG and then measured with F(ab′)₂ anti-C₃ ELISA. The lower detection limit was 4 μg/ml of heat aggregated human IgG (HAHG). Intra-assay coefficient of variation (CV) was 4.9–8.3%. High levels of CIC are found in the sera of patients with systemic lupus erythematosus (SLE), hepatitis B and stomach cancer.
Anti-vascular endothelial cell antibodies in severe preeclampsia
1990, American Journal of Obstetrics and Gynecology
There is mounting evidence to suggest that vascular endothelial cell injury plays an important role in the pathogenesis of preeclampsia. In this study an enzyme-linked immunoassay was used to demonstrate increased binding of immunoglobulins G and M to human umbilical vein endothelial cells by sera from women with severe preeclampsia as compared with normal pregnant control women. Fifty percent of women with preeclampsia versus 15.4% of control women had either immunoglobulin G or immunoglobulin M binding. In addition, immunofluorescent staining of normal renal cortical tissue with preeclamptic sera showed increased binding of immunoglobulin G to arterioles in patients with anti-vascular endothelial cell antibodies. These antibodies were not directed at HLA antigens and did not cross react with platelets. Interferon--y stimulation did not increase immunoglobulin binding. Antibodies to antigens expressed on vascular endothelial cells may be important in mediating the endothelial damage seen in preeclampsia. (AM J OBSTET GYNECOI. 1990;162:138-46.)
Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: Frequency and clinical significance
1988, Clinical Immunology and Immunopathology
This study examined the frequency of anti-vascular endothelial cell (VEC) antibodies (Ab) in 72 patients with IgA nephropathy (IgAN), and their possible relationship to clinical and histological parameters of the disease. An enzyme immunoassay was developed to measure the binding of sera to endothelial cells grown to a confluent monolayer. Thirty-two percent of IgAN patients had serum anti-VEC activity as compared to 4% of controls (P = 0.004) and 9% of patients with other primary glomerulonephritis (P = 0.017). This was shown to be due to anti-HLA class I Abs in 6 of the 23 IgAN patients, and in the 1 control positive for anti-VEC activity. Hence 17 IgAN patients had anti-VEC Abs, predominantly of the IgA subclass. Stimulation of the endothelial cells with interferon-γ and interleukin 1 did not increase the binding of these Abs. There was no correlation with circulating immune complex (IC) levels, and removal of ICs in positive sera by ultracentrifugation did not decrease anti-VEC binding. Significant correlations were found between anti-VEC Abs and proteinuria greater than 1 g/day (P = 0.044), as well as IgA anti-VEC Abs and C3 or IgA deposition in renal arterioles (P = 0.048). These IgA Abs may be an important marker of pathogenetic activity in IgAN.
Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy
1987, Clinical Immunology and Immunopathology
Alimentary antigenic challenge has been postulated to have a role in the genesis of IgA circulating immune complexes (CIC), resulting in mesangial IgA disease. In this study, we examined the relationship between bovine serum albumin (BSA) and IgA CIC in patients with IgA nephropathy. Of the 47 patients studied, elevated IgA CIC levels were found in 32% by the F(ab′)₂ anti-C₃ and Raji cell enzyme immunoassays (EIA). Elevated IgA anti-BSA antibody levels were found in 9 patients, and there was a positive correlation between these levels and IgA CIC as measured in the Raji cell EIA (R = 0.60, P < 0.001). In 4 patients with elevation of both IgA CIC and IgA anti-BSA antibody levels, solubilization experiments were done to demonstrate the presence of BSA antigen in the IgA CIC. Using the Raji cell EIA, the IgA CIC levels decreased significantly after preincubating the sera with serial concentrations of excess BSA. No corresponding effect was seen with human serum albumin used as control. Hence, BSA may be the antigenic stimulus in the formation of IgA CIC in selected patients with IgA nephropathy. The pathogenic capacity of these IgA-BSA CIC remains to be determined.
Petechiae and urticaria after DTP vaccination: Detection of circulating immune complexes containing vaccine-specific antigens
1986, The Journal of Pediatrics

View all citing articles on Scopus

View full text

Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab′)2 anti-C3 micro enzyme immunoassays

Abstract

Adv. Immunol.

Clin. Immunol. Immunopathol.

Adv. Immunol.

Clin. Exp. Immunol.

Nature (London)

Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab′)₂ anti-C₃ micro enzyme immunoassays